Zivo Bioscience Inc (ZIVO)

$7.96

Market is closed - opens 7 PM, 04 Jun 2024

Insights on Zivo Bioscience Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 72.6% return, outperforming this stock by 124.4%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 304.2%

Performance

  • $3.13
    $7.97
    $7.96
    downward going graph

    60.68%

    Downside

    Day's Volatility :60.73%

    Upside

    0.13%

    downward going graph
  • $0.48
    $13.00
    $7.96
    downward going graph

    93.97%

    Downside

    52 Weeks Volatility :96.31%

    Upside

    38.77%

    downward going graph

Returns

PeriodZivo Bioscience IncIndex (Russel 2000)
3 Months
-11.56%
0.0%
6 Months
1229.44%
0.0%
1 Year
-52.7%
0.0%
3 Years
-69.08%
-22.6%

Highlights

Market Capitalization
22.5M
Book Value
- $0.93
Earnings Per Share (EPS)
-3.81
PEG Ratio
0.0
Wall Street Target Price
12.0
Profit Margin
0.0%
Operating Margin TTM
-16072.75%
Return On Assets TTM
-338.92%
Return On Equity TTM
-3956.02%
Revenue TTM
27.7K
Revenue Per Share TTM
0.02
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
20.0K
Diluted Eps TTM
-3.81
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-2.76
EPS Estimate Next Year
-2.2
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Zivo Bioscience Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 50.75%

Current $7.96
Target $12.00

Technicals Summary

Sell

Neutral

Buy

Zivo Bioscience Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zivo Bioscience Inc
Zivo Bioscience Inc
6.13%
1229.44%
-52.7%
-69.08%
-68.34%
Moderna, Inc.
Moderna, Inc.
21.03%
85.08%
14.68%
-28.27%
659.22%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
3.22%
20.18%
31.88%
93.3%
227.58%
Novo Nordisk A/s
Novo Nordisk A/s
8.85%
34.38%
71.83%
235.07%
463.44%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
16.81%
34.1%
40.6%
123.97%
174.53%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zivo Bioscience Inc
Zivo Bioscience Inc
NA
NA
0.0
-2.76
-39.56
-3.39
NA
-0.93
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.14
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.89
28.89
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.97
46.97
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.59
29.59
0.53
17.08
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zivo Bioscience Inc
Zivo Bioscience Inc
Buy
$22.5M
-68.34%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$54.6B
659.22%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
227.58%
28.89
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$602.6B
463.44%
46.97
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$117.5B
174.53%
29.59
39.46%

Institutional Holdings

  • BARTLETT & Co WEALTH MANAGEMENT LLC

    0.01%

Company Information

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Organization
Zivo Bioscience Inc
Employees
8
CEO
Mr. John B. Payne
Industry
Consumer Non-Durables

FAQs